MX2024007632A - Una composicion farmaceutica para el tratamiento de infecciones oticas. - Google Patents
Una composicion farmaceutica para el tratamiento de infecciones oticas.Info
- Publication number
- MX2024007632A MX2024007632A MX2024007632A MX2024007632A MX2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- pharmaceutical composition
- otic infections
- infections
- otic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291673P | 2021-12-20 | 2021-12-20 | |
| PCT/EP2022/086649 WO2023117900A1 (en) | 2021-12-20 | 2022-12-19 | A pharmaceutical composition for the treatment of otic infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024007632A true MX2024007632A (es) | 2024-07-09 |
Family
ID=84942883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024007632A MX2024007632A (es) | 2021-12-20 | 2022-12-19 | Una composicion farmaceutica para el tratamiento de infecciones oticas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049827A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4452269B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024547035A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118434420A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022421489A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239989A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3050117T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007632A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023117900A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2576589C (en) | 2004-08-13 | 2013-11-12 | Schering-Plough Ltd. | Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid |
-
2022
- 2022-12-19 CN CN202280084383.8A patent/CN118434420A/zh active Pending
- 2022-12-19 US US18/720,093 patent/US20250049827A1/en active Pending
- 2022-12-19 MX MX2024007632A patent/MX2024007632A/es unknown
- 2022-12-19 WO PCT/EP2022/086649 patent/WO2023117900A1/en not_active Ceased
- 2022-12-19 AU AU2022421489A patent/AU2022421489A1/en active Pending
- 2022-12-19 ES ES22843140T patent/ES3050117T3/es active Active
- 2022-12-19 EP EP22843140.9A patent/EP4452269B1/en active Active
- 2022-12-19 CA CA3239989A patent/CA3239989A1/en active Pending
- 2022-12-19 JP JP2024536463A patent/JP2024547035A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4452269B1 (en) | 2025-09-03 |
| EP4452269A1 (en) | 2024-10-30 |
| AU2022421489A1 (en) | 2024-06-06 |
| CA3239989A1 (en) | 2023-06-29 |
| WO2023117900A1 (en) | 2023-06-29 |
| CN118434420A (zh) | 2024-08-02 |
| US20250049827A1 (en) | 2025-02-13 |
| JP2024547035A (ja) | 2024-12-26 |
| ES3050117T3 (en) | 2025-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024005716A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
| CO2018001407A2 (es) | Composiciones con potenciadores de permeación para suministro de fármacos | |
| CR20240363A (es) | Compuestos y métodos para el tratamiento de infecciones virales. | |
| CO2020008825A2 (es) | Regímenes de dosificación superior de g1t38 | |
| MX2023006504A (es) | Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo. | |
| ECSP077239A (es) | Formulación farmacéutica | |
| MX2023002671A (es) | Formulaciones agradables. | |
| CL2021000924A1 (es) | Uso de reboxetina para el tratamiento de narcolepsia | |
| MX2021003830A (es) | Uso terapéutico del glucagón y combinación que incluye el mismo. | |
| CL2024001052A1 (es) | Formulaciones y sistemas de erdafitinib para administración intravesical. | |
| CL2020002544A1 (es) | Inhibidor de ret para uso en tratar cáncer que tiene una alteración de ret | |
| CL2019002218A1 (es) | Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular. | |
| MX2019015927A (es) | Composiciones para administración de fármacos y métodos de uso de las mismas. | |
| MX2017016774A (es) | Agente terapeutico para la fibrosis. | |
| AR115913A1 (es) | Formas de dosificación oral biodisponibles, uso, métodos | |
| MX2022002444A (es) | Granulo recubierto, dispersion solida y preparacion que contiene hidrobromuro de vortioxetina enmascarante de sabor oral. | |
| CO2021014253A2 (es) | Formulación de tableta vaginal | |
| AR126393A1 (es) | Terapia combinada para el tratamiento de enfermedades hepáticas | |
| CO2020001881A2 (es) | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol | |
| MX2024007944A (es) | Derivados de 4-fenil-tetrahidropiridina para el tratamiento de enfermedades auditivas. | |
| LT3968956T (lt) | Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui | |
| UA120529U (uk) | Спосіб збереження функції нирок у хворих, що страждають на подагру і метаболічний синдром | |
| MX2022007065A (es) | Parche de liberacion prolongada con amikacina para el tratamiento de infecciones cutaneas producidas por bacterias. | |
| UY40059A (es) | Una composición que comprende un principio activo y un ramnolípido | |
| CO2024013497A1 (es) | Combinación de celecoxib - acetaminofén de estabilidad mejorada y procedimiento para su preparación |